Nuvilex - NVLX

Nuvilex (NVLX)
Coverage: March 1, 2013 - March 1, 2014
Featured: March 1, 2013

Latest Newsletter Editions

spacer
Fri, Oct 17, 2014 @ 07:10 am
Hedge Fund Managers- Drowning At Their High Water Marks It seems like we might have had the capitulation sell off this week, with...
Mon, Jul 21, 2014 @ 06:07 am
Nuvilex (NVLX): Shutting Them Up It's been the only thing worth covering in July-It's been radio silence from Staffing 360 (STAF...
Sun, Jul 13, 2014 @ 08:07 am
Nuvilex (NVXL): A Tradeable Bottom? Well, it's July and we're in the middle of the summer doldrums. Microcap stocks are exceptionally...
Fri, May 30, 2014 @ 09:05 am
Nuvilex (NVLX): Don't Be Fooled By Quiet Trading It's been a rather quiet week on the trading front for Nuvilex (NVLX), but it's anything but quiet on the corporate front. It's...
Thu, May 1, 2014 @ 09:05 am
Nuvilex (NVLX): Proving My Theory Today The last edition I published on Nuvilex (NVLX) back on April 19th suggested we had finally...

Click Here For More Newsletters on NVLX

spacer

Latest Blog Entries

spacer

Quote Data

spacer
Last Trade: 0.1918 Bid: 0.0000
Last Size: 500 Ask: 0.0000
Trade Time: 4:59pm Bid x Ask Size: N/A
Change: up arrow +0.0058 (+3.12%) Day's Range: 0.00 - 0.00
Prev Close: 0.1860 52wk Range: 0.12 - 0.62
Open: 0.0000 P/E (ttm): N/A
Volume: 0 EPS (ttm): -0.0340
spacer [Chart]

Business Summary

spacer

Disclosure

spacer
MarketBtye LLC was formerly paid a fee of $10,000 and 1 million newly issued restricted shares of Nuvilex by the company for six months of coverage. The 6 months has expired. On November 1, 2013, MarketByte LLC entered into a consulting agreement with Nuvilex to cover the company for an additional 6 months and received 300,00 newly issued restricted shares. MarketByte LLC currently holds no shares of Nuvilex, and has received $83,155.83 in proceed from sales of NVLX in 2014. At present, MarketByte LLC has no contractual obligation to provide coverage of Nuvilex. Therefore, there are no conflicts of interest.

Recent News Headlines

spacer
PharmaCyte Biotech Diabetes Consortium Member Publishes Review Article on Use of Genetic Engineering to Treat Diabetes
Fri, 13 Feb 2015 15:54:38 GMT
[at noodls] - PharmaCyte Biotech Diabetes Consortium Member Publishes Review Article on Use of Genetic Engineering to Treat Diabetes
PharmaCyte Biotech's Partner Austrianova Opens New Facilities in Singapore
Sat, 31 Jan 2015 07:49:47 GMT
[at noodls] - PharmaCyte Biotech's Partner Austrianova Opens New Facilities in Singapore
Nuvilex Announces Name Change to PharmaCyte Biotech
Wed, 07 Jan 2015 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX) today announced that the Company has changed its name to PharmaCyte Biotech, Inc. Shares in PharmaCyte Biotech will trade under the new ticker symbol "PHCB" ...
15 Marijuana Stocks To Watch In 2015
Tue, 06 Jan 2015 16:45:54 GMT
Nuvilex to Attend 2015 Gastrointestinal Cancers Symposium in San Francisco, January 15-17, 2015
Tue, 06 Jan 2015 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX) today announced that its Chief Executive Officer (CEO), Kenneth L Waggoner, JD, and its Chief Operating Officer, Gerald W. Crabtree, Ph.D., will be attending ...
FDA Grants Orphan Drug Designation to Nuvilex for Pancreatic Cancer Treatment
Mon, 22 Dec 2014 15:43:59 GMT
[at noodls] - Share SILVER SPRING, MD, December 22, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, today announced ...
NUVILEX, INC. Financials
Sat, 20 Dec 2014 18:04:13 GMT
Nuvilex Provides Shareholder Update on Cancer and Diabetes Programs
Tue, 16 Dec 2014 08:53:31 GMT
[at noodls] - Share SILVER SPRING, MD, December 16, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company providing cell solutions for the treatment of diseases, today announced ...
Nuvilex Announces Name Change of Subsidiary to Viridis Biotech
Mon, 08 Dec 2014 17:17:29 GMT
[at noodls] - Share SILVER SPRING, MD., Dec. 8, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB: NVLX), a preclinical and clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, ...
Nuvilex Announces the Opening of Austrianova's cGMP Live Cell Encapsulation Facility in Thailand
Thu, 04 Dec 2014 18:28:46 GMT
[at noodls] - Share SILVER SPRING, MD, December 4, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced ...
Nuvilex Obtains Exclusive Worldwide License to Develop Disease Treatments that Combine Cell-in-a-Box® and Cannabinoid-Based Medicine
Mon, 01 Dec 2014 16:20:55 GMT
[at noodls] - Share SILVER SPRING, MD, December 1, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company developing cell therapy solutions for the treatment of diseases, announced ...
Nuvilex Executives in Southeast Asia To Further Advance Cell-in-a-Box Technology®
Fri, 21 Nov 2014 16:02:58 GMT
[at noodls] - Share SILVER SPRING, MD, November 21, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced ...
Breakthrough Diabetes Research to Be Commercialized by US-Based Nuvilex, Inc.
Mon, 03 Nov 2014 15:49:42 GMT
[Marketwired] - Australian research that has produced a line of insulin producing cells that could eliminate the need for injections for Type 1 diabetics will be commercialized by US company Nuvilex, Inc. and its subsidiaries ...
License For Insuline-Producing Cells Brings Nuvilex, Inc. Closer To “Bio-Artificial Pancreas” To Treat Type 1 Diabetes
Fri, 31 Oct 2014 09:43:07 GMT
[at noodls] - Share Nuvilex, Inc. plans to develop a diabetes treatment using its Cell-in-a-Box® platform technology. In 2013, the company acquired the exclusive worldwide rights to the cellulose-based-live-cell encapsulation ...
Nuvilex, Inc. Engaged in "Cutting Edge" Cannabis Preclinical Studies Using Model Compounds With Cell-in-a-Box
Wed, 29 Oct 2014 12:45:00 GMT
[Marketwired] - Nuvilex, Inc. isn't letting the upcoming mid-term elections or the views in Washington, D.C., on medical marijuana slow down its research. The company is currently engaged in preclinical studies at the ...
Nuvilex, Inc. Moves Closer to "Bio-Artificial Pancreas" Diabetes Treatment With License for Insulin-Producing Cells
Tue, 21 Oct 2014 13:00:00 GMT
[Marketwired] - Nuvilex, Inc. has carefully mapped out its plan to develop a diabetes treatment using the Cell-in-a-Box® platform technology. It started in November 2013 when the company acquired the exclusive worldwide ...
Nuvilex's Cancer Treatment Obtaining FDA Orphan Drug Status Would Make Company Attractive Big Pharma Target
Tue, 14 Oct 2014 13:00:00 GMT
[Marketwired] - Nuvilex, Inc. has officially introduced its advanced pancreatic cancer treatment to the U.S. Food and Drug Administration in an application asking the agency to grant orphan drug status to its Cell-in-a-Box®/ifosfamide......
Cannabis Support on the Rise as Nuvilex and mCig Move Higher
Mon, 08 Sep 2014 16:00:00 GMT
[Accesswire] - WHITEFISH, MT / September 8, 2014 / Cannabis stocks moved largely lower over the past week amid ongoing profit taking following the industry’s run-up over the past year. Top gainers for the week included ...
Nuvilex Nears Crucial Quality of Life Study in Malignant Ascites Associated with Pancreatic and Other Abdominal Cancers
Wed, 23 Jul 2014 04:00:00 GMT
[Accesswire] - New York, NY / ACCESSWIRE / July 23, 2014 / Nuvilex, Inc. (OTCQB: NVLX) will begin preclinical studies in early August with its Contract Research Organization (CRO) Translational Drug Development (TD2) ...
Cannabis Stocks Edge Higher Last Week Led by Nuvilex & Entertopia
Tue, 22 Jul 2014 13:30:00 GMT
[Accesswire] - WHITEFISH, MT / July 22, 2014 / The Marijuana Index(TM) moved slightly higher last week, despite a 7% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares. Medbox Inc. (OTC: MDBX), the second largest component ...